APA (7th ed.) Citation

Saze, Z., Ohki, S., Hanayama, H., Hayase, S., Tada, T., Kono, K., . . . Nirei, A. (2019). Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 65(1), 6-12. https://doi.org/10.5387/fms.2018-12

Chicago Style (17th ed.) Citation

Saze, Zenichiro, et al. "Clinical Usefulness of Ramucirumab Plus Paclitaxel for Unresectable and Recurrent Gastric Cancer." FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 65, no. 1 (2019): 6-12. https://doi.org/10.5387/fms.2018-12.

MLA (9th ed.) Citation

Saze, Zenichiro, et al. "Clinical Usefulness of Ramucirumab Plus Paclitaxel for Unresectable and Recurrent Gastric Cancer." FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, vol. 65, no. 1, 2019, pp. 6-12, https://doi.org/10.5387/fms.2018-12.